New hope for breast cancer patients: drug combo may stop return of disease
NCT ID NCT07190443
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study tests whether adding the drug abemaciclib to standard hormone therapy can help prevent breast cancer from returning in people whose cancer came back in the same area (chest, breast, or nearby lymph nodes) after initial treatment. About 290 participants with a specific type of breast cancer (HR-positive, HER2-negative) will be randomly assigned to receive either hormone therapy alone or hormone therapy plus abemaciclib for two years. The goal is to see if the combination improves how long people live without their cancer coming back or spreading.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Institute Hospital of JFCR
RECRUITINGKoto-ku, Tokyo, 135-8550, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.